Physician profile
Brett E Smith
NPI 1689948879
$2,098.15
in general payments reported to CMS, 2019-2025
13 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $110 · 2021: $90.45 · 2022: $152 · 2023: $370 · 2024: $698 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $448.13 | 2024-2025 | Prostep Mica, Augment Injectable, Actishield |
| Treace Medical Concepts, INC. | $276.22 | 2025 | |
| Organogenesis INC. | $235.58 | 2023 | Puraply |
| Vilex LLC | $231.32 | 2024 | |
| Bioventus LLC | $194.98 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $174.42 | 2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $136.33 | 2020-2024 | Pico, Grafix Pl |
| Ortho Solutions INC | $134.75 | 2023 | |
| Depuy Synthes Sales INC. | $117.94 | 2022 | |
| Medline Industries Lp | $76.40 | 2021 | |
| Averitas Pharma INC. | $32.83 | 2024 | Qutenza |
| Abbott Laboratories | $22.37 | 2024 | Proclaim |
| Wright Medical Technology, INC. | $16.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.